Celebrating Rare Disease Day
What is Rare Disease Day? As scientific breakthroughs have emerged and modern forms of communication have connected patients, specialists, policy makers, activists, and support organizations across the word, the Rare …
Blog
Blog
Centene Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx)
PANTHERx is proud to join the Centene family of companies. Through this transaction, we are reaffirming our relentless commitment to transforming lives and removing barriers for individuals living with complex …
Centene Signs Definitive Agreement to Acquire PANTHERx Rare Pharmacy (PANTHERx)
Today is a transformative day and the culmination of a great deal of effort and diligence to support the future of PANTHERx. We are very excited to announce that we …
PANTHERx Rare® Pharmacy Chosen as Partner by Alnylam Pharmaceuticals for OXLUMO™ (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary Oxalate Levels
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Alnylam Pharmaceuticals, the leading RNAi therapeutics company, as a very limited distribution pharmacy partner …
Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, Named an EY Entrepreneur Of The Year® 2020 National Award Winner
Read the Official PANTHERx Press Release. Ernst & Young LLP (EY US) yesterday announced that Dr. Gordon J. Vanscoy, Chairman & CEO of both PANTHERx Rare and RareMed Solutions, was …
PANTHERx Rare Adds Another Best Places to Work Award
PANTHERx is pleased to announce the receipt of another Pittsburgh Business Times Best Places to Work Award, adding to a history of success. PANTHERx is not afraid to break molds, …
Dr. Gordon J. Vanscoy, PANTHERx Rare’s & RareMed’s CEO, Selected Again as a 2020 Smart 50 Award Honoree by Smart Business Magazine
Smart Business Magazine has announced that Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, was selected as a 2020 Smart 50 Award honoree. Since 2014, …
Dr. Gordon J. Vanscoy, PANTHERx Rare & RareMed’s Chairman & CEO, named a 2020 EY Entrepreneur of The Year® East Central Award Winner
Ernst & Young LLP (EY US) announced today that Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, was named a 2020 Entrepreneur of The Year® …
PANTHERx Pride: Award-Winning Management
In May of 2020 PANTHERx Rare Pharmacy shared the news that we had been officially recognized as a prestigious US Best Managed Company for overall business performance and sustained growth. …
PANTHERx® Rare Pharmacy Selected by Blueprint Medicines to Distribute GAVRETO™ (pralsetinib) for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Blueprint Medicines as a limited distribution partner for new drug GAVRETO™ (pralsetinib), which was …